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Abstract
Purpose: The body concentration of iron is regulated by a fine equilibrium between absorption and losses of iron.
Iron can be absorbed from diet as inorganic iron or as heme. Hemopexin is an acute phase protein that limits iron
access to microorganisms. Moreover, it is the plasma protein with the highest binding affinity for heme and thus it
mediates heme-iron recycling. Considering its involvement in iron homeostasis, it was postulated that hemopexin
may play a role in the physiological absorption of inorganic iron.
Methods and Results: Hemopexin-null mice showed elevated iron deposits in enterocytes, associated with higher
duodenal H-Ferritin levels and a significant increase in duodenal expression and activity of heme oxygenase. The
expression of heme-iron and inorganic iron transporters was normal. The rate of iron absorption was assessed by
measuring the amount of 57Fe retained in tissues from hemopexin-null and wild-type animals after administration of
an oral dose of 57FeSO4 or of 57Fe-labelled heme. Higher iron retention in the duodenum of hemopexin-null mice was
observed as compared with normal mice. Conversely, iron transfer from enterocytes to liver and bone marrow was
unaffected in hemopexin-null mice.
Conclusions: The increased iron level in hemopexin-null duodenum can be accounted for by an increased iron
uptake by enterocytes and storage in ferritins. These data indicate that the lack of hemopexin under physiological
conditions leads to an enhanced duodenal iron uptake thus providing new insights to our understanding of body iron
homeostasis.
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Introduction
The strong interest on iron nutrition and metabolism in both
developing and developed nations arises from the need to find
a remedy to the widely diffused metabolic disorders of iron
deficiency and overload. Several interdisciplinary studies of the
various aspects of iron nutrition, physiology, and biochemistry
have been carried out. Particular attention has been devoted to
studies about dietary and physiologic factors that modulate the
efficiency of iron absorption with the aim of elucidating
molecular mechanisms of intestinal absorption of iron. The
purpose is to formulate diets and dietary practices that
enhance iron availability and to unravel the precise pathways
and general features of intestinal iron absorption mechanism.
Despite many years of intense studies, many of these aspects
are still speculative and hypothetical.
Dietary iron absorption can be divided into intestinal uptake
(i.e., transport across the apical membrane of enterocytes) and
transfer (i.e., translocation through the cytoplasm and across
the basolateral membrane into the portal circulation). Anyway,
consensus has not yet been reached on the comprehensive
molecular mechanisms involved in iron passage into, across,
and out of the mucosal epithelial cells.
In mammals, the majority of iron is present as hemoglobin in
erythrocytes. The phagocytosis of senescent erythrocytes
mediated by macrophages ensures that a significant portion of
the iron is recycled. Nevertheless, a certain amount of iron is
daily lost through epithelial exfoliation, thus requiring
compensation by dietary iron absorption through duodenal
enterocytes. In the absence of important pathologies, the body
needs approximately 1 mg of iron per day to maintain iron
balance. Nonheme iron exists in two main forms, Fe(III) (the
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ferric form) and Fe(II) (the ferrous form). Most dietary iron is
nonheme iron, generally found in foods of vegetal origin.
Before absorption through the divalent metal transporter 1
(DMT1), Fe(III) in the diet must be reduced to Fe(II) at the
apical surface of enterocytes by the ferrireductase duodenal
cytochrome-b (Dcytb). Once in the cytosol, iron can be stored
in ferritin (Ft) or exported. The protein, poly (rC)-binding protein
1 (PCBP1) is involved in the translocation pathway of iron to
the iron storage Ft protein, while at the basolateral membrane
iron is transported out of the enterocyte into the portal blood
circulation by the iron-export protein ferroportin 1 (Fpn1) [1].
Iron exported by Fpn1 is then oxidised by hephaestin (Heph)
and bound by transferrin (Tf) in the circulation. The transferrin
receptor (TfR1), located at the basal membrane of enterocytes,
could eventually take up the circulating Tf-bound iron,
transporting it back in duodenal enterocytes.
Another source of dietary iron is heme. Heme results from
the breakdown of hemoglobin and myoglobin found in meat
products. Heme represents the most important source of
dietary iron in meat-eating animals, accounting for by one-third
of ingested iron in Western diets and up to two-thirds of
absorbed body iron. Although the molecule(s) mediating
duodenal brush–border enterocyte heme uptake has not yet
been clearly identified, there is considerable evidence to
suggest that uptake occurs via a receptor-mediated endocytotic
pathway or by the proton-coupled folate transporter/heme
carrier protein-1 (PCFT/HCP1), expressed at high levels in the
duodenum [1]. Once in the cytosol, heme is catabolised by
heme oxygenase (HO), giving rise to iron, carbon monoxide
and biliverdin. Moreover, the enterocytes express some heme
exporters, such as ATP-binding cassette sub-family G member
2 (ABCG2) [2] and feline leukaemia virus subgroup C receptor
1a (FLVCR1a) [3,4], although their function in duodenal heme
metabolism has not been described so far. Inside the
enterocytes heme controls several mechanisms, acting both as
a prosthetic group in hemoproteins, such as cytochromes, and
as a regulator of gene transcription.
The regulation of iron absorption in the intestine is finely
tuned in response to iron need in the organism and to iron
deposits in body tissues. Indeed, the process is adjusted
according to both the global body iron status and the local iron
status in the absorptive enterocytes. A complex network of
proteins that responds to and integrates systemic and local
signals is responsible for this homeostatic regulation of dietary
iron assimilation, ensuring sufficient iron uptake and avoiding
toxic iron accumulation.
The hepatic hormone hepcidin (Hepc), the hypoxia inducible
transcription factors (HIFs), the iron regulatory proteins (IRPs)
and the iron storage proteins ferritins are the main factors for
the regulation of systemic iron homoeostasis and cellular local
iron balance, respectively [5,6]. Hepc and HIF, in particular,
have been demonstrated to play a crucial role in the
modulation of iron uptake from dietary sources and transfer to
the organism to meet body iron requirements.
Hepc is a negative regulator of the Fpn1 protein located on
the basolateral membrane of enterocytes [7]. Hepc synthesis is
positively regulated by iron stores and Tf saturation, the latter
reflecting a steady state between iron influx into plasma and
iron uptake and utilization by the bone marrow and other
tissues. In iron deficiency or in case of high iron demand from
the erythropoietic compartment, such as during hemolysis,
hepatic Hepc production decreases, allowing enterocyte Fpn1
levels to increase, thus facilitating basolateral export of iron.
Moreover, in the presence of iron deficiency, the liver produces
and secretes into the circulation more apo-Tf and
ceruloplasmin, both of which favour the movement of iron into
the portal blood. Besides its regulatory role of body iron stores
in response to erythropoietic iron demand, Hepc is also
important in inflammatory events to decrease iron release in
plasma, thus limiting iron availability to pathogens [5].
Regarding HIFs, evidence has been gained to prove that
they act as central mediators of cellular adaptation to critically
low oxygen levels in both normal and compromised tissues.
Several of their target genes are involved in iron homeostasis,
reflecting the molecular links between oxygen homeostasis and
iron metabolism [8–10].
HIFs allow the cells of peripheral tissues to sense the oxygen
delivered by erythrocytes in order to modulate iron supply to
the bone marrow for erythropoiesis. Furthermore, iron is a
necessary cofactor in the post-translational modification of
HIFs, thus explaining how HIFs, other than oxygen, can also
sense iron and consequently regulate the expression of target
genes involved in iron handling [11].
Hemopexin (Hx) is a glycoprotein whose major function has
been so far described during hemolysis or systemic massive
heme overload [12,13]. In these conditions, Hx binds and
transports heme to hepatocytes, where heme can be efficiently
catabolised [14]. Hx or heme-Hx complexes regulate gene
expression [15,16], act as signaling molecules and exert
important functions in the nervous and immune system [12]. As
Hepc, Hx is a plasma protein released by liver, its production is
regulated during hemolysis and inflammatory events and it is
considered an acute phase protein [13]. For this reason,
additional functions for Hx in the control of iron trafficking can
be postulated.
This work describes a role for Hx in modulating iron uptake
by duodenum under physiologic conditions.
Materials and Methods
Animals
Wild-type and Hx-null mice in the 129Sv genetic background
were fed on a standard diet (4RF25 GLP, Mucedola, Settimo
Milanese, Milano, Italy) containing 8 mg/kg and 292 mg/kg
heme-iron and inorganic iron respectively, and received water
ad lib. All experiments were approved by the animal studies
committee of the University of Torino, Italy.
Tissue iron measurement
57Fe isotope and total Fe were determined using inductively
coupled plasma mass spectrometry (ICP-MS) (Element-2;
Thermo-Finnigan, Rodano (MI), Italy) at medium mass
resolution (M/ΔM ~4000). To this purpose, sample lysis was
performed with 2 ml of concentrated HNO3 (70%) under
microwave heating at 160°C for 20 minutes (Milestone
MicroSYNTH Microwave labstation equipped with an optical
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fiber temperature control and HPR-1000/6M six position high-
pressure reactor, Bergamo, Italy). After lysis, the volume of
each sample was brought to 3 ml with ultrapure water and the
sample was analyzed by ICP-MS. A natural abundance iron
standard solution was analyzed during sample runs in order to
check changing in the systematic bias. The calibration curve
was obtained using four iron absorption standard solutions
(Sigma-Aldrich) in the range 0.2–0.05 µg/ml.
Tissue iron was also measured by the BPS-based
colorimetric method and by DAB (methanol 3,3 diamino-
benzidine) enhanced Perls’ stain, as previously reported [17].
57Fe and 57Fe-heme absorption
For 57Fe absorption analyses, the stable iron isotope 57Fe
(57Fe at 94% enrichment; Frontier Scientific Inc., Logan, Utah
USA) was used as tracer.
A 0.4 mol/L solution of 57FeSO4 has been prepared by
overnight dissolution of 22.85 g 57Fe/L in 0.4 mol/L H2SO4
(Sigma Aldrich, Milano, Italy). The obtained 57FeSO4 solution
was stored at 4°C. Before its use, 87.7 mg sucrose and 0.83
mg ascorbic acid per mg iron were added to the 57FeSO4
solution to yield to a final concentration of 57Fe of 20 mmol/L,
ascorbic acid of 5.38 mmol/L and sucrose of 10%, respectively.
As negative control, an analogous solution without tracer
was prepared.
Both the 57FeSO4-labelled and the control solution were
adjusted to pH=7 by adding the required volume of 1 mol/L
NaOH.
For 57Fe-heme absorption analyses, 10mg of 57Fe(III)
Protoporphyrin IX chloride (Frontier Scientific Inc., Logan, Utah
USA) were dissolved in the required volume of DMSO 100% to
yield a final concentration of 20 mmol/L. The obtained solution
was stored at 4°C.
To assess the in vivo absorption of 57FeSO4 or 57Fe-heme, 20
µl of 57FeSO4-labelled solution (correspondent to 22.8 µg 57Fe)
or 20 µl of 57Fe-heme labelled solution (correspondent to 22.8
µg 57Fe contained in 260.8 µg 57Fe-heme) were orally
administered to overnight fasted mice. Control mice received
vehicle solution. During the experiment mice received water ad
lib. Tissues were collected at different times after the
administration. Control mice represented the “0” time point of
the experiment.
The amount of 57Fe retained by the tissue upon the
administration of 57FeSO4-labelled or 57Fe-heme labelled
solutions was determined by inductively coupled plasma mass
spectrometry (ICP-MS) and expressed as μg of 57Fe per g of
wet tissue, taking into account the amount of naturally
occurring 57Fe.
The percentage natural abundance of 57Fe in tissues of wild-
type and Hx-null animals was checked before 57Fe and 57Fe-
heme absorption analyses, resulting comparable in the two
groups (Figure S1).
Further details on the experimental procedure are reported in
[18].
Heme oxygenase activity
HO activity was evaluated in tissue microsomal fractions by
measuring bilirubin production. Briefly, frozen tissue samples
were prepared by homogenization in hypotonic buffer (10
mmol/L Tris-HCl buffer pH 7.4, 2 mmol/L MgCl2) with protease
inhibitors (aprotinin, leupeptin, pepstatin; Cocktail Tablets,
Roche Diagnostics). After 15 minutes incubation on ice,
samples were sonicated and the homogenates were then
adjusted to 0.25 mol/L sucrose. After centrifugation for 10
minutes at 1000g, the supernatant was removed and
centrifuged for an additional 15 minutes at 12000g before being
ultracentrifuged at 33000 rpm for 1 hour. The supernatant was
discarded and the microsomal pellet was used for HO activity
measurement. The enzyme reaction method was used in a 200
µl mixture (prepared in potassium phosphate buffer 100
mmol/L, pH 7.4, 2mmol/L MgCl2) containing 150 µg microsomal
proteins, 25 µmol/L hemin, 1 mmol/L NADPH, 2 mmol/L
glucose-6-phosphate (G6P), 0.5 U G6P dehydrogenase, and 1
mg of rat liver cytosol proteins (33000 rpm supernatant) as a
source of biliverdin reductase.
Rat liver supernatant was prepared fresh by homogenization
in 0.1 mol/L sodium citrate buffer, pH 5, containing 10%
glycerol, and centrifugation at 12000g for 15 minutes before
ultracentrifugation at 33000 rpm for 1 hour.
Following 1 hour incubation in the dark at 37°C, the bilirubin
generated was measured in a spectrophotometer at 464 nm
and 530 nm. A control reaction containing all components
except the protein extract was used for the spectrophotometric
blank. The bilirubin was calculated by the difference in
absorption between 464 and 530 nm. Results were expressed
as pmol bilirubin/mg microsomal protein/h.
Immunohistochemistry and Western blotting
Immunohistochemistry and Western blotting were performed
according to standard procedures using antibodies against L-
and H-ferritin [19], heme oxygenase (HO)-1 and -2 (Stressgen
Bioreagents, Ann Arbor, MI, USA), ferroportin (Fpn) 1 [20],
divalent metal transporter (DMT) 1 [21], transferrin receptor
(TfR) 1 (Invitrogen, San Giuliano Milanese, Italy), proton-
coupled folate transporter/heme carrier protein 1 (PCFT/HCP1)
[22], and actin (Santa Cruz Biothecnology Inc., Santa Cruz,
California, USA).
Real Time PCR analysis
Total RNA was extracted using Purelink micro to midi RNA
exctraction kit (Invitrogen, San Giuliano Milanese, Italy) and
analyzed by quantitative real-time polymerase chain reaction
(qRT-PCR). To this end, 1µg total RNA was transcribed into
complementary DNA (cDNA) by M-MLV reverse transcriptase
(Invitrogen, San Giuliano Milanese, Italy) and random primers
(Invitrogen, San Giuliano Milanese, Italy). qRT-PCR was
performed on a 7300 Real Time PCR System (Applied
Biosystems, Monza, Italy) as previously reported [16]. qRT-
PCR analysis was performed using the Universal Probe Library
system (Roche). Primers and probes were designed using the
ProbeFinder software (www.roche-applied-science.com).
Transcript abundance, normalized to 18S mRNA expression, is
expressed as a fold increase over a calibrator sample.
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Statistical Analysis
Results were expressed as mean ±SEM. Statistical analyses
were performed using two-way analysis of variance followed by
the Bonferroni correction for multiple group comparisons. An
unpaired Student’s t-test was used when only two groups were
compared. A P value of less than 0.05 was regarded as
significant.
Results
Hx deficiency results in increased iron deposits in the
duodenum
To assess the role of Hx in the iron absorption, iron content
in duodenum and peripheral tissues of Hx-null and wild-type
mice was evaluated by means of three different modalities.
First, duodenal iron content was determined by the BPS-
based colorimetric method. A significant iron accumulation was
detected in the duodenum of Hx-null mice compared to age-
matched wild-type controls (Table 1), whereas liver, spleen,
kidney and serum iron levels were comparable in the two
groups of mice [17]. Duodenal iron content was similar in 2 and
6 month-old Hx-null mice. This observation supports the view
that the detected amount of iron likely represents the maximal
iron capacity of duodenal mucosa, a tissue with a rapid
turnover. The increased iron content in the duodenum of Hx-
null mice was confirmed by ICP-MS measurements (Figure
1A). Furthermore, iron staining by DAB enhanced Perls’
reaction on tissue sections clearly showed higher iron deposits
in Hx-null mice duodenum than in wild-type controls (Figure
1B).
Iron loading in Hx-null animals was associated with an
increase in H-ferritin (H-Ft) expression in duodenal enterocytes
(Figure 2A, B), whereas L-Ft level did not show a significant
change (Figure 2C).
Hx deficiency does not affect the expression of
duodenal iron transporters
To get more insight into the molecular mechanisms
underlying iron overload, the expression of DcytB, DMT1,
Fpn1, TfR1 and Heph in the duodenum has been assessed.
qRT-PCR analysis showed that DcytB, DMT1, Fpn1 and Heph
mRNA levels were not altered in Hx-null mice compared to
wild-type animals, while TfR1 mRNA level was higher in Hx-null
mice than in controls (Figure 3A). Since duodenum cells
express two types of DMT1 and Fpn1 transcripts, that differ for
the presence or absence of an Iron Responsive Element (IRE)
sequence in their C-terminus or N-terminus [23,24]
respectively, specific qRT-PCR assays able to discriminate
between the isoforms were set up. The qRT-PCR results
showed that both DMT1-IRE and DMT1-noIRE were expressed
at comparable levels in the duodenum of Hx-null and wild-type
mice (Figure 3B). An analogous result was found for IRE
containing and not-containing Fpn1 transcripts (Fpn1A and
Fpn1B in Figure 3C). Moreover, as Fpn1 is mainly regulated at
post-transcriptional level by the hepatic hormone Hepc, the
level of Hepc expression in the liver has been assessed. As
shown in Figure 3D, Hepc expression did not result altered in
Hx-null mice when compared to controls. Consistently with
mRNA data, DMT1 and Fpn1 protein expression was similar in
Hx-null and wild-type duodenum (Figure 3E). Interestingly,
TfR1 protein showed a similar abundance in Hx-null and wild-
type mice (Figure 3E), in contrast with the results obtained by
measuring TfR1 transcript level.
Hx deficiency results in enhanced heme catabolism in
duodenum without an increased expression of
duodenal heme transporters
As duodenal iron deposits in Hx-null mice could derive from
altered heme catabolism and/or heme trafficking in
enterocytes, the activity and expression of HO as well as the
expression of heme transportes were evaluated.
HO activity was higher in the duodenum of Hx-null mice than
in that of wild-type animals (Figure 4A). Western blot analysis
on total duodenal lysates did not show differences in the
expression of both HO-1 and HO-2 between Hx-null and wild-
type mice (Figures 4B and S2A). Nevertheless,
immunohistochemistry on duodenal sections showed an
increased expression of HO-1 in duodenal villi of Hx-null mice
(Figure 4B). In these animals, HO-1 immunoreactivity yielded a
strong, continuous signal along the villi. At cellular level, HO-1
expression appeared higher in the apical cytoplasm of
enterocytes, and decreased along their apical-basal axis
(shown at high magnification in Figure 4B). On the contrary, in
wild-type animals, the HO-1-positive signal along the villi
appeared weaker and discontinuous whereas the subcellular
pattern of expression was similar to that observed for Hx-null
mice. As expected for a constitutive isoform, the HO-2 signal
was similar in Hx-null and wild-type mice (Figure S2B).
To assess whether the increased heme catabolism in the
duodenum of Hx-null mice could be associated to an altered
heme import from the intestinal lumen or to an altered export to
plasma, it was decided to analyze the expression of PCFT/
HCP1 and FLVCR1, the most well-characterized heme
importer and exporter respectively. As shown in Figure 5A and
5B, PCFT/HCP1 and FLVCR1 mRNA and PCFT/HCP1 protein
resulted expressed at similar levels in the duodenum of Hx-null
and wild-type mice. In addition, when mRNA levels of other
heme exporters were evaluated, it was found that the ATP-
binding cassette, subfamily G, member 2 (ABCG2), as well as
the intracellular heme transporter Heme Regulated Gene
(HRG)-1 were unchanged in Hx-null duodenum (Figure 5A).
Table 1. Hx deficiency results in increased iron deposits in
the duodenum.
 2 months old mice 6 months old mice
Wild-type 91.07 ± 12.06 (n=7) 129.0 ± 13.40 (n=4)
Hx-null 221.5 ± 26.08 (n=12) 252.4 ± 36.19 (n=4)
P value 0.0020 0.0187
Measurement of tissue iron in the duodenum of 2 and 6 months-old wild-type and
Hx-null mice. Values are expressed as μg/g dry tissue. Note the significantly higher
iron levels in the Hx-null mice duodenum compared to wild-type mice at both ages.
Comparison between mice of the same genotype at 2 and 6 months of age did not
reveal significant differences.
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Figure 1.  Hx deficiency results in increased iron deposits in the duodenum.  (A) Total iron content in the duodenum of 2
month-old wild-type and Hx-null mice measured by ICP-MS. Values are expressed as μg iron/g wet tissue. Data represent mean ±
SEM; n=10; * = P<0.05. (B) Duodenal sections of a wild-type mouse (i, ii) and an Hx-null mouse (iii, iv) at 2 months of age stained
with DAB enhanced Perls’ reaction. Note the more intense staining in the duodenum of the Hx-null mouse. Bar i, iii = 500µm; bar ii,
iv = 100µm.
doi: 10.1371/journal.pone.0068146.g001
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Figure 2.  Increased H-Ft expression in Hx-null mice duodenum.  Representative Western blots of H-Ft (A) and L-Ft (C)
expression in the duodenum of wild-type and Hx-null mice. Band intensities were measured by densitometry and normalized to actin
expression. Densitometry data represent mean ± SEM; n=3 for each genotype. (B) Duodenal sections of a wild-type mouse (i) and
an Hx-null mouse (ii) processed by immunohistochemistry with an anti-H-Ft antibody. The H-Ft-positive signal is increased in the
duodenum of the Hx-null animal. Bar= 100µm.
doi: 10.1371/journal.pone.0068146.g002
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Figure 3.  Hx deficiency does not affect the expression of
duodenal iron transporters.  (A) qRT-PCR analysis of DcytB,
DMT1, Fpn1, TfR1 and Heph expression in the duodenum of
wild-type and Hx-null mice. These assays do not discriminate
between the different DMT1 and Fpn1 isoforms. The results of
specific qRT-PCR assays for DMT1-IRE and DMT1-noIRE
expression and for Fpn1A and Fpn1B expression are shown in
(B) and (C), respectively. (D) qRT-PCR analysis of Hepc
expression in the liver of wild-type and Hx-null mice. In A-D,
transcript abundance, normalized to 18S RNA expression, is
expressed as a fold increase over a calibrator sample. Data
represent mean ± SEM, n= 6 for each genotype. (E)
Representative Western blots of DMT1, Fpn1 and TfR1
expression in the duodenum of wild-type and Hx-null mice.
Band intensities were measured by densitometry and
normalized to actin expression. Densitometry data represent
mean ± SEM; n=3 for each genotype. Results shown are
representative of 3 independent experiments.
doi: 10.1371/journal.pone.0068146.g003
Thus, the increased heme catabolism in duodenum cells of
Hx-null mice cannot be accounted for by an impaired
expression of heme transporters.
Hx deficiency results in an enhanced iron uptake in the
duodenum
To assess the rate of iron absorption, an oral dose of
57FeSO4 or of 57Fe-labelled heme was administered to Hx-null
and wild-type mice. 57Fe content in duodenum, liver, bone
marrow and kidney was determined by inductively coupled
plasma mass spectrometry (ICP-MS) analysis [18] at different
times after the administration.
Thirty minutes after 57FeSO4 administration, a higher amount
of 57Fe was detected in the duodenal mucosa of treated mice
as compared with controls, and the quantity of 57Fe retained by
duodenum further increased at ninety minutes after the oral
administration. The amount of 57Fe retained in the mucosa was
significantly higher in the duodenum of Hx-null mice than in that
of wild-type animals (Figure 6A).
Similar results were obtained when 57Fe labelled heme (57Fe-
heme) was orally administered (Figure 6B).
Analyses of liver and bone marrow showed comparable
quantities of 57Fe in both Hx-null and wild-type mice after
57FeSO4 administration (Figure 7A, B). The transfer of 57Fe to
the kidney, an organ only marginally involved in iron handling,
was negligible in both genotypes (Figure 7C).
Collectively, these data showed that, upon an oral
administration of 57FeSO4 or of 57Fe-labelled heme, iron
accumulation in the duodenal mucosa of Hx-null mice was
higher than in wild-type animals, whereas the 57Fe transport
from the duodenal mucosa to peripheral tissues appeared
unaffected. This demonstrates that the lack of Hx leads to an
enhanced duodenal iron uptake.
Discussion
The herein reported results demonstrate that the lack of Hx
in plasma leads to an enhanced iron uptake in the duodenum,
whereas iron transfer from duodenal mucosa to the body
appears unaffected. The net result is an abnormal iron
accumulation in enterocytes. Systemic iron balance is not
affected by the lack of Hx as demonstrated by the normal Hepc
expression, normal iron deposits in other tissues and normal
hematological parameters in Hx-null mice [25].
The expression of iron transporters is not affected in
duodenum cells of Hx-null mice despite the occurrence of
increased iron deposits. Both DMT1-IRE and DMT1-noIRE as
well as Fpn1A and Fpn1B are expressed at similar levels in Hx-
null and wild-type mice. Moreover, TfR1 mRNA level is higher
in Hx-null mice duodenum as compared with controls, but the
amount of TfR1 protein is comparable in the two genotypes.
Overall, these findings indicate that iron loading in the
duodenum of Hx-null mice does not lead to significant changes
in the activity of Iron Responsive Proteins (IRPs) [6]. This
conclusion is further supported by the lack of induction of the
expression of L-Ft in Hx-null duodenum, whereas the up-
regulation of H-Ft appears to be controlled at a transcriptional
level, likely by the increased amounts of dietary heme taken up
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Figure 4.  Hx deficiency results in enhanced heme catabolism in the duodenum.  (A) HO activity in the duodenum of wild-type
and Hx-null mice. Data represent mean ± SEM; n= 8 for each genotype. * = P<0.05. (B) Representative Western blot of HO-1
expression in the duodenum of wild-type and Hx-null mice. Band intensities were measured by densitometry and normalized to actin
expression. Densitometry data represent mean ± SEM; n=3 for each genotype. (C) Sections of the duodenum of a wild-type mouse
(i, iv, vii) and an Hx-null mouse (ii, v, viii) stained with an antibody to HO-1. Enlarged details of sections i, ii, iii are shown in iv, v, vi
respectively The HO-1-positive signal was more intense in the Hx-null mouse than in the wild-type control (arrows) Sections on the
right (iii, vi, ix) represent negative controls in which the primary antibody was omitted. Bar i, ii, iii = 100µm; bar iv, v, vi = 57 µm; bar
vii, viii, ix = 20 µm.
doi: 10.1371/journal.pone.0068146.g004
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Figure 5.  Hx deficiency does not affect the expression of duodenal heme transporters.  (A) qRT-PCR analysis of PCFT/
HCP1, FLVCR1, ABCG2 and HRG-1 expression in the duodenum of wild-type and Hx-null mice. Transcript abundance, normalized
to 18S RNA expression, is expressed as a fold increase over a calibrator sample. Data represent mean ± SEM, n= 6 for each
genotype. (B) Representative Western blot of PCFT/HCP1 expression in the duodenum of wild-type and Hx-null mice. Band
intensities were measured by densitometry and normalized to actin expression. Densitometry data represent mean ± SEM; n=3 for
each genotype. Results shown are representative of 3 independent experiments.
doi: 10.1371/journal.pone.0068146.g005
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Figure 6.  Hx deficiency results in enhanced iron uptake in the duodenum cells.  (A) 57Fe retention in the duodenal mucosa of
wild-type and Hx-null mice measured by ICP-MS 30, 60, 90, 135 and 180 minutes after oral administration of a solution containing
20 mmol/L 57FeSO4. Control mice were administered vehicle solution and represented the “0” time point of the experiment. Values
are expressed as μg 57Fe/ g tissue. Data represent mean ± SEM; n=6 for each experimental point; *** = P<0.001 (comparing control
mice with the corresponding group of 57FeSO4-administered mice), # # = P<0.01 (comparing the two genotypes). (B) 57Fe retention
in the duodenal mucosa of wild-type and Hx-null mice measured by ICP-MS 30, 60, 90 and 135 minutes after oral administration of
a solution containing 20 mmol/L 57Fe labelled heme (57Fe-heme). Control mice were administered vehicle solution and represented
the “0” time point of the experiment. Values are expressed as μg 57Fe/ g tissue. Data represent mean ± SEM; n=6 for each
experimental point; *** = P<0.001 (comparing control mice with the corresponding group of 57Fe-heme-administered mice), # =
P<0.05 (comparing the two genotypes).
doi: 10.1371/journal.pone.0068146.g006
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Figure 7.  Hx deficiency does not affect iron transfer from the duodenum to other tissues.  (A) 57Fe retention in the liver of
wild-type and Hx-null mice measured by ICP-MS 30, 60, 90, 135 and 180 minutes after oral administration of a solution containing
20 mmol/L 57FeSO4. Control mice were administered vehicle solution and represented the “0” time point of the experiment. Values
are expressed as μg 57Fe/ g tissue. Data represent mean ± SEM; n=6 for each experimental point; * = P<0.05, ** = P<0.01
(comparing control mice with the corresponding group of 57FeSO4-administered mice). (B) 57Fe retention in the bone marrow of wild-
type and Hx-null mice measured by ICP-MS 48 hours after oral administration of a solution containing 20 mmol/L 57FeSO4. Control
mice were administered vehicle solution and represented the “0” time point of the experiment. Values are expressed as μg 57Fe/ g
tissue. Data represent mean ± SEM; n=10 for each experimental point; * = P<0.05. (C) 57Fe retention in the kidney of wild-type and
Hx-null mice measured by ICP-MS 30, 60, and 90 minutes after oral administration of a solution containing 20 mmol/L 57FeSO4.
Control mice were administered vehicle solution and represented the “0” time point of the experiment. Values are expressed as μg
57Fe/ g tissue. Data represent mean ± SEM; n=6 for each experimental point.
doi: 10.1371/journal.pone.0068146.g007
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by the Hx-null mice duodenum cells [26]. These results are
quite surprising at the light of previous studies reporting a
strong down-regulation of DMT1-IRE, together with an
upregulation of L- and H-Ft, upon iron overload [27].
Nevertheless, in those experiments animals experienced an
acute iron overload as they were challenged with a high iron
dose (10 mg oral iron/rat). Moreover, DMT1 and Ft modulation
after the iron dose was transient as the level of both proteins
returned to basal values by 72 hours after iron administration.
The situation encountered in the case of Hx-null mice appears
different as they only ingested a limited quantity of iron with
their daily diet. Our results indicate that a continuous and
sustained iron uptake in duodenum is not sufficient to alter the
activity of IRPs.
As far as TfR1 is concerned, it is interesting to note that the
mRNA level of this receptor is up-regulated in Hx-null mice
duodenum. This finding may indicate that, besides the IRE-
IRPs system, different mechanisms could be involved in the
regulation of TfR1 mRNA level, such as the modulation of
transcription and/or mRNA stability. Nevertheless, the resulting
protein level is comparable in Hx-null mice and wild-type
controls, thus indicating that iron overload in Hx-null duodenum
could not be ascribed to an altered expression of TfR1.
Another interesting feature deals with the increased HO-1
activity and expression observed in Hx-null mice as compared
with wild-type animals.
Hx-null mice show enhanced 57Fe retention following 57Fe-
heme administration, indicating increased duodenal heme
uptake. The enhanced chronic dietary heme absorption in Hx-
null mice could be responsible for the increased HO-1 activity
and expression. Alternatively, the enhanced HO activity might
derive from an impaired heme export through FLVCR1a or
ABCG2 in the enterocytes of Hx-null mice. Although FLVCR1a
and ABCG2 mRNA levels in Hx-null mice are comparable to
those ones of wild-type mice, it could be hypothesized that the
activity of these transporters is compromised in Hx-null mice.
Notably, in vitro experiments have demonstrated that Hx
interacts with FLVCR1a favouring cellular heme export [28].
Hx plasma levels are finely regulated during several
pathological conditions. Hx is an acute phase protein and its
plasma level raises during inflammatory events thanks to a
transcriptional induction mediated by the cytokine interleukin 6
[13]. In these conditions Hx, by binding heme derived from
dietary sources or hemolytic events, limits iron availability to
pathogens thus inhibiting their growth. From the results
obtained in this work it could be surmised that, in the presence
of inflammation, Hx increase in plasma may have a role in
inhibiting duodenal iron uptake, thus further contributing to limit
bacterial expansion. On the other hand, Hx has been
demonstrated to disappear from plasma in the presence of
strong hemolytic processes, as the rate of its synthesis in the
liver is not sufficient to replace its consumption [29]. Therefore,
in the latter case, the depletion of Hx in the bloodstream might
favour iron uptake in the duodenum, thus enhancing iron
supply to erythropoietic compartments in a situation of high iron
demand for red blood cells production. Moreover, the
enhanced duodenal HO activity associated to Hx deficiency
can further contribute to increase the amount of iron available
to meet body iron requirement.
Interestingly, it has been reported that Hepc is upregulated
by inflammation and strongly down-regulated during hemolysis
[30] with the result of causing the blockage or the enhancement
of iron export from duodenum cells, respectively. Thus, one
may speculate that Hx and Hepc could cooperate to reduce
iron absorption in case of inflammation and to enhance it
during hemolysis. From this point of view the Hx-null mouse
could be considered a model in which the axis Hx-Hepc is
uncoupled (as Hx is absent while Hepc level is normal), thus
justifying the presence of duodenal iron deposits in Hx-null
mice.
The mechanism underlying the increase of duodenal iron
uptake in the absence of Hx remains to be elucidated. As
stated above, the expression of the most important duodenal
inorganic iron and heme transporters is unaffected in Hx-null
mice, thus suggesting the occurrence of alternative
mechanisms other than transcriptional or translational
regulation of these proteins.
An intriguing hypothesis is that Hx may modulate the activity
of a specific transporter in duodenal cells. Of course, the fact
that the regulation of iron uptake by Hx involves iron
transporters exposed on the apical membrane of the
enterocytes suggests that Hx can interact with a receptor
activating a signalling pathway inside the absorptive cell.
Consistently, the only known Hx receptor is LRP1/CD91 [31]
which is ubiquitously expressed.
In a paper by Rish et al. [32] it was demonstrated that highly
proliferative cells are characterized by a plasma membrane
electron transport (PMET) that enables cells to transfer
electrons from intracellular reductants, like NADH, to
extracellular electron acceptors. Among electron acceptors,
Rish et al. indicated the heme-Hx complex as one of the best
physiological candidates for this function. A challenging idea is
that plasma Hx, by generating heme-Hx complexes, might
favour PMET contributing to maintain the typical steady state
membrane potential of enterocytes. It might be possible that
when Hx plasma levels are modified, as under pathological
conditions, the general membrane potential of enterocytes may
be altered. As the membrane potential is a pivotal regulator of
iron and heme transporters activity, its modification can be
associated to an enhanced or reduced heme and iron uptake/
release. Further investigations are required to test these
hypotheses.
In conclusion, the herein reported results show that the lack
of Hx yields an increased duodenal iron uptake. This finding
offers new perspectives for future studies aimed at
investigating the reciprocal relationship between Hx and other
hormones in the regulation of body iron homeostasis and
possibly at identifying strategies to increase/reduce iron
absorption in the therapy of metabolic disorders of iron
deficiency and overload.
Supporting Information
Figure S1.  57Fe natural abundance in tissues.  Percentage
of naturally occurring 57Fe in serum and tissues from wild-type
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and Hx-null animals determined by ICP-MS. Values are
expressed as percentage of 57Fe respect to total iron. Data
represent mean ± SEM, n= 10 for each genotype.
(TIF)
Figure S2.  Hx deficiency does not affect duodenal HO-2
expression.  (A) Representative Western blot of HO-2
expression in the duodenum of wild-type and Hx-null mice.
Band intensities were measured by densitometry and
normalized to actin expression. Densitometry data represent
mean ± SEM; n=3 for each genotype. (B) Sections of the
duodenum of a wild-type mouse (i, iv) and an Hx-null mouse (ii,
v) stained with an antibody to HO-2. The HO-2-positive signal
was comparable in the Hx-null mouse and in the wild-type
control (arrows). Sections on the right (iii, vi) represent negative
controls in which the primary antibody was omitted. Bar i, ii, iii =
100µm; bar iv, v, vi = 20 µm.
(TIF)
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